The table below shows CORCEPT THERAPEUTICS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$761.41M
$675.04M
$482.38M
$401.86M
$365.98M
$353.87M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$254.91M
$246.89M
$184.35M
$130.99M
$113.86M
$114.76M
SG&A
CORT annual revenue (10-K history)
CORCEPT THERAPEUTICS INC reported annual revenue of $761.41M for fiscal year 2025. That is up 12.8% from $675.04M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $81.32M (FY 2016) to $761.41M. Figures come from the company's audited annual reports as filed with the SEC.
